PDS Biotechnology Corp reports results for the quarter ended June 30 - Earnings Summary
I'm PortAI, I can summarize articles.
PDS Biotechnology Corp reported a quarterly adjusted loss of 21 cents per share for the quarter ended June 30, an improvement from a loss of 23 cents in the same quarter last year. The company reported a total loss of $9.43 million with zero revenue. Analysts had expected a loss of 23 cents per share. PDS shares fell 7.5% this quarter and 24.5% year-to-date. The average analyst rating is "buy" with a 12-month price target of $5.00, indicating a potential upside of 75.4% from the last closing price of $1.23.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments